欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (7): 774-777.

• 定量药理学 • 上一篇    下一篇

氨氯地平联合替米沙坦改善高血压合并糖尿病患者微蛋白尿效果的Meta分析

汪全海1,2, 贺连平2, 陈燕2, 金岳龙2, 姚应水2   

  1. 1皖南医学院成人教育学院,芜湖 241002,安徽;
    2皖南医学院预防医学系,芜湖 241002,安徽
  • 收稿日期:2013-03-16 修回日期:2013-05-06 出版日期:2013-07-26 发布日期:2013-06-20
  • 通讯作者: 姚应水,男,教授,硕士生导师,研究方向:慢性病分子流行病学。E-mail:yingshuiyao@163.com
  • 作者简介:汪全海,男,硕士,讲师,研究方向:慢性病行为流行病学。Tel: 0553-3932351 E-mail: qh2144@163.com贺连平,共同第一作者,男,硕士,助教,研究方向:慢性病分子流行病学。Tel: 0553-3932466 E-mail: 1983helianping@163.com
  • 基金资助:
    国家自然科学基金项目(81072367);安徽省自然科学基金项目(090413126、1308085MH135);安徽省高校省级自然科学研究项目(KJ2008A098)

Effects of amlodipine plus telmisartan for ameliorating microalbuminuria in hypertension patients with diabetes:A meta-analysis

WANG Quan-hai1,2, HE Lian-ping2, CHEN Yan2, JING Yue-long2, YAO Ying-shui2   

  1. 1School of Continuing Education, Wannan Medical College, Wuhu 241002, Anhui, China;
    2Department of Preventive Medicine, Wannan Medical College, Wuhu 241002,Anhui,China
  • Received:2013-03-16 Revised:2013-05-06 Online:2013-07-26 Published:2013-06-20

摘要: 目的: 评价氨氯地平联合替米沙坦改善高血压合并糖尿病患者微蛋白尿的疗效。方法: 计算机检索OVID-LWW、CNKI和万方数据库,收集以氨氯地平联合替米沙坦为干预措施改善高血压合并糖尿病 24 h 微量尿蛋白含量的随机对照试验研究(RCT)。评价纳入研究进行方法学质量,提取有效数据进行Meta分析。结果: 共纳入5个RCT,共450例高血压合并糖尿病患者。试验组采用氨氯地平联合替米沙坦治疗,对照组采用单纯替米沙坦治疗,Meta分析结果显示,治疗前,治疗前两组 24 h 微量蛋白尿含量比较差异无统计学意义(P>0.05)。治疗后,两组 24 h 微量蛋白尿含量差异有统计学意义(P<0.05)。结论: 氨氯地平联合替米沙坦为干预措施改善高血压合并糖尿病24 h微量尿蛋白含量效果良好。但因纳入文献的试验方法学质量较低,仍需大样本、长期不良反应随访。

关键词: 氨氯地平, 替米沙坦, 高血压, 糖尿病, Meta分析

Abstract: AIM: To evaluate the efficacy of amlodipine plus telmisartan in improving microalbuminuria of subjects with hypertension and diabetes.METHODS: Electronic databases of OVID-LWW, CNKI and Wanfang were searched to collect randomized controlled trials(RCT) by interventions of amlodipine plus telmisartan in improving microalbuminuria of subjects with hypertension and diabetes, the methodological quality of the trials and extracted valid data for Meta-analysis was evaluated.RESULTS: 5 RCT and 500 patients were included. Test group were treated by amlodipine plus telmisartan, the control group were treated by telmisartan. Meta analysis showed that no statistically significant was found for 24 h microalbuminuria between two groups before treatment, but statistically significant was found after treatment. CONCLUSION: Amlodipine plus telmisartan can improve 24 h microalbuminuria of subjects with hypertension and diabetes, hypertension and diabetes 24 h trace urine protein content to good effect. However, because of the lower methodological quality literature, it is still necessary to need a large sample, and long-term adverse reactions follow-up.

Key words: Amlodipine, Telmisartan, Hypertension, Diabetes, Meta analysis

中图分类号: